Ohio Board of Pharmacy Bans Synthetic Kratom as Illegal Drug

The Ohio Board of Pharmacy has taken significant action by approving an emergency rule that classifies synthetic kratom as a Schedule I illegal drug. This decision, made on October 6, 2023, aims to address growing concerns about the safety and potential health risks associated with synthetic versions of the substance.

Synthetic kratom, which is manufactured to mimic the effects of the natural kratom plant, has been linked to serious health issues, including addiction and overdose. The board’s decision reflects an increasing awareness of these dangers and a commitment to protecting public health in Ohio.

The emergency rule allows law enforcement agencies to pursue legal action against those who manufacture, distribute, or possess synthetic kratom. This measure is part of a broader strategy to combat the rising tide of synthetic drugs, which have been a growing concern across the United States.

The board’s ruling has sparked mixed reactions among local advocates and health professionals. Some support the ban as a necessary step to safeguard individuals from the harmful effects of synthetic substances, while others argue that it may limit access to natural alternatives that some users find beneficial.

As part of its ongoing efforts, the Ohio Board of Pharmacy has emphasized the importance of public education regarding the potential risks associated with synthetic drugs. The board plans to work collaboratively with community organizations to raise awareness and provide resources for individuals seeking help with substance use disorders.

In light of this new rule, the Ohio Board of Pharmacy will monitor the situation closely and assess the impact of the ban on drug-related health issues within the state. The board is prepared to make further adjustments to its policies as needed to ensure the safety and well-being of Ohio residents.

Ultimately, the classification of synthetic kratom as a Schedule I illegal drug marks a pivotal moment in Ohio’s approach to synthetic drug regulation, highlighting the state’s commitment to public health and safety. The board’s actions come as part of a nationwide trend to address the evolving challenges posed by synthetic substances, reflecting a growing urgency to respond to the complexities of modern drug use.